Literature DB >> 23849331

Cerebral blood flow measured by arterial-spin labeling MRI: a useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis.

Gang Zheng1, Long Jiang Zhang, Jianhui Zhong, Ze Wang, Rongfeng Qi, Donghong Shi, Guang Ming Lu.   

Abstract

PURPOSE: To investigate the role of arterial-spin labeling (ASL) MRI to non-invasively characterize the patterns of cerebral blood flow (CBF) changes in cirrhotic patients and to assess the potential of ASL MRI to characterize minimal hepatic encephalopathy (MHE).
MATERIALS AND METHODS: This study was approved by the local ethics committee, and written informed consent was obtained from all participants. Thirty six cirrhosis patients without overt hepatic encephalopathy (16 MHE patients and 20 non hepatic encephalopathy (non-HE) patients) and 25 controls underwent ASL MRI, and CBF was measured for each subject. One-way ANOCOVA test with age and gender as covariences was used to compare CBF difference among three groups, and post hoc analysis was performed between each two groups. Region-based correlation analysis was applied between Child-Pugh score, venous blood ammonia level, neuropsychological tests and CBF values in cirrhosis patients. Receiver operator characteristic (ROC) analysis was used for assessing CBF measurements in ASL MRI to differentiate MHE from non-HE patients.
RESULTS: The gray matter CBF of MHE patients (71.09 ± 11.88 mL min(-1)100g(-1)) was significantly higher than that of non-HE patients (55.28 ± 12.30 mL min(-1)100g(-1), P<0.01) and controls (52.09 ± 9.27 mL min(-1)100g(-1), P<0.001). Voxel-wise ANOCOVA results showed that CBFs were significantly different among three groups in multiple gray matter areas (P<0.05, Bonferroni corrected). Post hoc comparisons showed that CBF of these brain regions was increased in MHE patients compared with controls and non-HE patients (P<0.05, Bonferroni corrected). CBF of the right putamen was of the highest sensitivity (93.8%) and moderate specificity (75.0%) for characterization of MHE when using the cutoff value of 50.57 mL min(-1)100g(-1). CBFs in the bilateral median cingulate gyri, left supramarginal gyrus, right angular gyrus, right heschl gyrus and right superior temporal gyrus have both sensitivity and specificity of approximately 80% for the diagnosis of MHE.
CONCLUSION: Higher CBF was found in many brain regions in cirrhotic patients than controls and gradually increased with the progress of disease. CBF measured with ASL MRI can be a useful marker for differentiating MHE from non-HE patients.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ASL; Arterial-spin labeling; CBF; Cerebral blood flow; Cirrhosis; DST; HE; Hepatic encephalopathy; MCC; MHE; NCT-A; OHE; PET; ROC; SPECT; TIPS; arterial spin labeling; cerebral blood flow; digit symbol test; hepatic encephalopathy; median cingulate cortex; minimal hepatic encephalopathy; non hepatic encephalopathy; non-HE; number-connection test type A; overt hepatic encephalopathy; positron emission tomography; receiver operator characteristic; single photon emission computed tomography; transjugular intrahepatic portosystemic shunt.

Mesh:

Substances:

Year:  2013        PMID: 23849331     DOI: 10.1016/j.ejrad.2013.06.002

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  16 in total

1.  Altered coupling of regional cerebral blood flow and brain temperature in schizophrenia compared with bipolar disorder and healthy subjects.

Authors:  Miho Ota; Noriko Sato; Koji Sakai; Mitsutoshi Okazaki; Norihide Maikusa; Kotaro Hattori; Hiroaki Hori; Toshiya Teraishi; Keigo Shimoji; Kei Yamada; Hiroshi Kunugi
Journal:  J Cereb Blood Flow Metab       Date:  2014-09-03       Impact factor: 6.200

Review 2.  Multimodal MR imaging in hepatic encephalopathy: state of the art.

Authors:  Xiao Dong Zhang; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2018-01-26       Impact factor: 3.584

Review 3.  Advances in cirrhosis: Optimizing the management of hepatic encephalopathy.

Authors:  Andy Liu; Ryan B Perumpail; Radhika Kumari; Zobair M Younossi; Robert J Wong; Aijaz Ahmed
Journal:  World J Hepatol       Date:  2015-12-18

4.  Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.

Authors:  Gang Zheng; Hanzhang Lu; Wenkui Yu; Song Luo; Ya Liu; Wei Liu; Hui Liu; Long Wu; Lijuan Zheng; Xiang Kong; Long Jiang Zhang; Guang Ming Lu
Journal:  Eur Radiol       Date:  2017-05-18       Impact factor: 5.315

Review 5.  Cirrhotic Multiorgan Syndrome.

Authors:  Søren Møller; Flemming Bendtsen
Journal:  Dig Dis Sci       Date:  2015-06-26       Impact factor: 3.199

Review 6.  Multimodality magnetic resonance imaging in hepatic encephalopathy: an update.

Authors:  Xiao-Dong Zhang; Long-Jiang Zhang; Sheng-Yong Wu; Guang-Ming Lu
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

7.  Identifying minimal hepatic encephalopathy in cirrhotic patients by measuring spontaneous brain activity.

Authors:  Hua-Jun Chen; Ling Zhang; Long-Feng Jiang; Qiu-Feng Chen; Jun Li; Hai-Bin Shi
Journal:  Metab Brain Dis       Date:  2016-02-17       Impact factor: 3.584

8.  Disrupted Brain Intrinsic Networks and Executive Dysfunction in Cirrhotic Patients without Overt Hepatic Encephalopathy.

Authors:  Zhe-Ting Yang; Hua-Jun Chen; Qiu-Feng Chen; Hailong Lin
Journal:  Front Neurol       Date:  2018-01-25       Impact factor: 4.003

9.  Chinese guidelines on management of hepatic encephalopathy in cirrhosis.

Authors:  Xiao-Yuan Xu; Hui-Guo Ding; Wen-Gang Li; Ji-Dong Jia; Lai Wei; Zhong-Ping Duan; Yu-Lan Liu; En-Qiang Ling-Hu; Hui Zhuang; Chinese Society Of Hepatology; Chinese Medical Association
Journal:  World J Gastroenterol       Date:  2019-09-28       Impact factor: 5.742

10.  APOE Polymorphism Affects Brain Default Mode Network in Healthy Young Adults: A STROBE Article.

Authors:  Yun Yan Su; Xue Liang; U Joseph Schoepf; Akos Varga-Szemes; Henry C West; Rongfeng Qi; Xiang Kong; Hui Juan Chen; Guang Ming Lu; Long Jiang Zhang
Journal:  Medicine (Baltimore)       Date:  2015-12       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.